Australia asked the European Commission on Friday to review a decision by Italy to block the export of a shipment of AstraZeneca corona vaccines from the European Union.

A batch of 250,000 vaccines may not be exported to Australia from Italy and the European Commission, it was announced on Thursday.

AstraZeneca has been supplying less to the EU than agreed for some time now.

Deliveries next spring are also threatening to disappoint.

If a vaccine manufacturer does not meet its obligations, EU countries and the European Commission can block exports.

A manufacturer has to inform the EU country where it operates about a planned export for more than a month.

That country, in this case Italy, submits its decision to the committee.

He has the last word.

Italy reported the export refusal late last week, British business newspaper

The Financial Times



Australia has raised the issue with the European Commission through various channels.

"Specifically, we asked the committee to review this decision," said Australian Health Minister Greg Hunt (pictured).

According to Hunt, holding back the shipment will not delay the number of vaccinations.

Australia had already received 300,000 doses of the AstraZeneca vaccine, which should be enough until the vaccine can soon be widely produced locally as well.

The country expects to be able to use the first AstraZeneca injections that are locally produced by the end of March.

See also: This is the technology behind the AstraZeneca and Janssen vaccines